Amalgamated Bank Acquires 444 Shares of Amedisys, Inc. (NASDAQ:AMED)

Amalgamated Bank increased its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 2.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 15,593 shares of the health services provider’s stock after buying an additional 444 shares during the quarter. Amalgamated Bank’s holdings in Amedisys were worth $1,416,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in AMED. Pacer Advisors Inc. grew its position in Amedisys by 11,621.9% during the fourth quarter. Pacer Advisors Inc. now owns 558,197 shares of the health services provider’s stock worth $50,679,000 after buying an additional 553,435 shares in the last quarter. Polar Asset Management Partners Inc. acquired a new stake in shares of Amedisys in the third quarter valued at approximately $28,953,000. Verition Fund Management LLC raised its position in shares of Amedisys by 608.1% during the third quarter. Verition Fund Management LLC now owns 114,774 shares of the health services provider’s stock worth $11,077,000 after acquiring an additional 98,565 shares during the last quarter. Westchester Capital Management LLC lifted its position in Amedisys by 9.5% during the 3rd quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider’s stock valued at $107,976,000 after purchasing an additional 97,476 shares during the period. Finally, Calamos Advisors LLC grew its holdings in Amedisys by 22.7% during the 4th quarter. Calamos Advisors LLC now owns 487,444 shares of the health services provider’s stock worth $44,255,000 after acquiring an additional 90,097 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Price Performance

Amedisys stock opened at $92.00 on Tuesday. The company’s 50-day moving average price is $91.55 and its two-hundred day moving average price is $93.10. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a market cap of $3.01 billion, a P/E ratio of 36.51, a P/E/G ratio of 1.78 and a beta of 0.73. Amedisys, Inc. has a twelve month low of $82.15 and a twelve month high of $98.95.

Amedisys (NASDAQ:AMED) last announced its earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.09). The firm had revenue of $598.05 million for the quarter, compared to the consensus estimate of $602.38 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. As a group, analysts expect that Amedisys, Inc. will post 4.4 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Stephens reissued an “equal weight” rating and issued a $101.00 price target on shares of Amedisys in a report on Wednesday, February 12th. Five investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.